Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia

Autor: Quintarelli, Concetta, De Angelis, Biagio, Errichiello, Santa, Caruso, Simona, Esposito, Nicola, Colavita, Irene, Raia, Maddalena, Pagliuca, Simona, Pugliese, Novella, Risitano, Antonio M., Picardi, Marco, Luciano, Luigia, Saglio, Giuseppe, Martinelli, Giovanni, Pane, Fabrizio
Zdroj: In Leukemia Research February 2014 38(2):236-242
Databáze: ScienceDirect
Externí odkaz: